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ABSTRACT 
 
 
Histone deposition proteins CAF-1 and Asf-1 impact multiple aspects of 
chromosome formation and are essential in yeast to prevent DNA damage and avoid 
chromosomal rearrangement. Using fractionated yeast cell extracts, this MQP attempted 
to identify stimulatory factors which are necessary and sufficient for histone deposition 
by CAF-1 and/or Asf1. Identification of these cofactors, would provide insight into the 
reaction pathway and mechanism of histone deposition. Results were inconclusive, but 
improvements were proposed for the future success of this project.  
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Chapter 1. BACKGROUND
Histone Deposition 
  DNA must be compacted and organized in the nucleus of eukaryotes. For this 
purpose, eukaryotic DNA is assembled into nucleoprotein filaments known as chromatin. 
Chromatin is essential for compacting genomic DNA and for governing gene expression 
processes (Kaufman and Almouzni 2006). Chromatin establishes genetic and epigenetic 
states of DNA. Nucleosomes are the repeating structure of chromatin and are composed 
of 146 bp of DNA wrapped around a core histone octamer (Luger et al. 1997). The 
histone octamer includes an (H3/H4)2 tetramer1 and two H2A/H2B dimers. The 
composition of chromatin is modulated during DNA replication, transcription, repair, and 
recombination (Kaufman and Almouzni 2006).  During DNA replication, the chromatin 
structure must be duplicated with each replication of a genome. This mechanism involves 
the disassembly of parental histone octamers into dimers and tetramers which are 
redistributed equally between the two daughter DNA strands and completed with 
additional newly synthesized tetramers and dimers, which mix randomly with the 
parental tetramers and dimers to form the octamers on the daughter DNA during 
chromatin assembly following replication (Jackson et al. 1975; Jackson 1990; 
Annunziato 2005). The current model for chromatin assembly is a step-wise process. The 
(H3/H4)2 heterotetramer is deposited on DNA first1, followed by the two H2A/H2B 
dimers which complete the histone octamer (Annunziato 2005). DNA is wrapped around 
                                                 
1 A recent study suggests that histones form an H3H4 heterodimer rather than a heterotetramer in the cell 
(Tagami et al. 2004). Follow-up studies have shown that the stoichiometry of the Asf1-H3H4 complex is a 
single Asf1 molecule bound to an H3H4 heterodimer (English et al. 2005). A model for the deposition of 
two H3H4 heterodimers has been proposed, but not yet proven (English et al. 2005). 
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the octamer and the nucleosome is finally completed with the linker histone H1 
(Annunziato 2005). Histone deposition occurs almost immediately after new DNA is 
synthesized, which is important for the avoidance of DNA damage or replication fork 
collapse (Hoek and Stillman 2003; Ye et al. 2003; Franco et al. 2005; Groth et al. 2005).   
 
 
 
Figure 1. Histone Deposition during DNA Replication. At a replication fork, DNA Polymerases (pol) replicate 
DNA in the 5’? 3’ direction, using separated parental strands as templates. The primase Pol α begins the replication 
until proliferating cell nuclear antigen (PCNA) is loaded onto the DNA, displacing pol α. PCNA is a sliding-clamp 
protein which forms a ring around the DNA. It slides along the DNA bound to pol δ which completes the 
replication. Histones are deposited on the newly synthesized DNA in a step-wise manner with the assistance of 
histone chaperones such as CAF-1 and Asf1, which work synergistically. Parental and newly synthesized histone 
tetramers and dimers mix together, and are randomly selected for deposition. Histone chaperones assist in bringing 
the H3H4 tetramer to the DNA and depositing it. CAF-1 deposits the tetramer on the DNA. The H2A/H2B dimer is 
then deposited, completing the histone core. Daughter nucleosomes contain a random mix of parental and newly 
synthesized histone subunits.  
 
 
Histone chaperones such as chromatin assembly factor 1 (CAF-1) and 
Antisilencing function 1 (Asf1) mediate nucleosome assembly and disassembly. CAF-1, 
an evolutionarily conserved protein complex, is the best characterized replication-coupled 
chromatin assembly factor. CAF-1 is comprised of 3 subunits: Cac1, Cac2, and Cac3. 
CAF-1 and Asf1 are believed to bind different regions of the histone core and work 
 7
synergistically to deposit the H3H4 tetramer on DNA 1 (Smith and Stillman 1989; Tyler 
et al. 1999). Asf1 physically interacts with the p60/Cac2 subunit of CAF-1 (Tyler et al. 
2001; Krawitz et al. 2002; Mello et al. 2002). Asf1 is also involved in the disassembly of 
the tetramer from chromatin during transcriptional regualtion, (Adkins and Tyler 2004; 
Adkins et al. 2004). The majority of non-chromatin-bound histones are bound to Asf1 
prior to their assembly into chromatin (Groth et al. 2005). 
Purpose of MQP 
As mentioned earlier, histone deposition proteins impact multiple aspects of 
chromosome formation. Furthermore, CAF-1 and Asf1 impact the inheritance of 
chromatin structures in all eukaryotic organisms. These proteins are essential in yeast 
cells to prevent DNA damage and avoid chromosomal rearrangement. However, there is 
still little understanding of the mechanisms of these processes which directly effect 
genome stability. As part of a large scale study of the fundamental aspects of histone 
inheritance, experimentation in the laboratory of Paul Kaufman has demonstrated that a 
fractionated yeast extract supported CAF-1-mediated chromatin assembly. Previous data 
demonstrated that CAF-1 requires unidentified cofactors (Shibahara, 1999). 
 Further fractionation of the yeast cell extracts should lead to the isolation of 
specific factors involved in the stimulation of chromatin assembly. This MQP attempted 
to identify stimulatory factors which are necessary and sufficient for histone 
deposition by CAF-1 and/or Asf1 in the yeast Saccharomyces cerevisiae extracts. To 
accomplish this, isolation of intermediates involved in stimulating nucleosome assembly 
was attempted from fractionated yeast whole cell extract (WCE).  
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Yeast WCE was fractionated on a Q sepharose column and tested using 
biochemical supercoiling assays to detect the presence of possible stimulatory factors. 
Biochemical supercoiling assays were designed to recapitulate CAF-1-mediated histone 
deposition in vitro, which leads to the formation of nucleosomes and triggers supercoiling 
of the DNA. This method was used to facilitate detection of necessary and sufficient 
cofactors involved in histone deposition by the appearance of supercoiling in the assay 
results. Stimulatory activity of the fractionated extracts is estimated based on the 
robustness of the supercoiling signals. Upon detection of supercoiling, which denotes the 
presence of cofactors, further chromatographic fractionation and additional biochemical 
assays will be conducted. Purified materials used in this study include CAF-1, Asf1, type 
I topoisomerase, and dsDNA.  
Future Studies 
Upon isolation of CAF-1 activating proteins, involvement of the proteins in 
chromosome formation will be tested in vivo. Upon identification of the cofactors, 
experiments would be designed to gain insight into the reaction pathway and mechanism 
of histone deposition. For instance, if the depletion of the cofactors affects recruitment of 
CAF-1 to DNA replication or repair foci, it may be determined if the cofactor contributes 
to the localization of CAF-1. This could be tested with standard immunofluorescense 
protocols. Also, if an isolated cofactor demonstrated to be involved in stimulating histone 
deposition, it might also stimulate histone exchange between CAF-1 molecules or also 
from CAF-1 to Asf1. Future research related to this MQP involves greater in-depth 
studies of histone deposition mechanisms, chromosome biology, S phase progression, 
and genome stability. Paul Kaufman and his laboratory intend to pursue such studies. 
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Chapter 2. METHODS 
Materials 
Histones 
 The H3/H4 histone tetramers and H2A/H2B histone dimers were provided by 
Corey Smith. These were isolated from chicken erythrocytes and purified as described by 
von Holt et al (1989).  
 
Asf1 
 BL21 Rossetta cells, a strain of Escherichia coli, were transformed with two 
plasmids containing full length Asf1 (pPK238) and H3/H4 (pPK490). The transformed 
cells coexpressing Asf1 and H3/H4 were selected using LB plates containing 35 μg/mL 
CAM, 25 μg/mL KAN, and 10 μg/mL AMP, and then grown in a suspension of LB 
media. After a 4-hour induction with 1mM IPTG the cells were pelleted. Cell pellets were 
resuspended in Talon Lysis buffer and sonicated. Purifying full length Asf1 involved 
binding the clarified suspension to Talon beads (BD Biosciences), centrifugation, and 
elution with the Qiagen® Immidizole purification system. The peak fractions visualized 
at 280nm (see Appendix A) were pooled and concentrated via Vivaspin 6 10K MWCO 
spin concentrator. Full length Asf1 was separated from truncated Asf1 by elution over an 
S200 gel filtration column via the AKTA Ion Exchange Chromatography purification 
system in order to obtain uniform and concentrated full length Asf1. Purification of the 
samples was monitored by migration on a 17% SDS-polyacrylamide gel. The native 
molecular weight of Asf1 is 31.6D and the tagged fusion protein migrates to 43 kD. A 
Bradford assay was conducted to determine protein concentration using the Bio-Rad 
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Protein Assay system. Absorbance was measured at O.D.595.  The concentration of Asf1 
in the primary pool collected (fractions 45 to 47) was 0.316 mg/mL. This stock of Asf1 
was used in supercoiling assays.  
CAF-1 and hTopoisomerase I 
 SF21 insect cells were grown in a suspension of Grace’s Insect Media containing 
10% each fetal bovine serum, L-Glutamine, and amino acids.  CAF-1-infected and 
hTopo-infected SF21 cells were constructed using standard baculovirus procedures as 
described in the Baculovirus Expression Vectors laboratory manual (O’Reilly et al. 
1992). Virus titering was conducted by serial dilution in order to calculate the amount of 
virus required for infection in plaque forming units per mL (pfu/mL). The calculated 
pfu/mL for each virus is shown in Table 1.  
Table 1. Virus Titers 
Virus pfu/mL 
Cac-1 2.29x107
Cac-2 5.22x107
Cac-3 2.90x107
hTopo 3.14x107
CAF-1 
A large scale infection of the SF21 insect cells with Cac-1, Cac-2, and Cac-3 was 
conducted for the production of CAF-1. Equal stoichiometric amounts of Cac-1, Cac-2, 
and Cac-3 were required for the production of CAF-1. SF21 cells were infected with each 
of Cac-1, Cac-2, and Cac-3 at an MOI of 5 pfu/cell. After infection and 36-hour 
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incubation, cells were harvested and the purification of CAF-1 was carried out by Corey 
Smith. Nuclear and cytosolic extracts were saved for future use.   
 hTopo 
A large scale infection of the SF21 insect cells with hTopo was conducted for the 
production of hTopo. SF21 cells were infected with hTopo at an MOI of 5 virus 
particles/cell. After infection and 48-hour incubation, cells were harvested. Purification 
of the hTopo was performed by Corey Smith. A supercoiling assay was conducted to 
compare the new preparation to the previously used stock and titer the amount of the new 
hTopo preparation required for sufficient relaxation in the supercoiling assays. The 
capability of the prepared hTopo was inadequate for the supercoiling assays. Subsequent 
experimentation used vvTopo which proved effective in the assays. 
Vaccinia Virus type I Topoisomerase 
 Vaccinia Virus type I  Topoisomerase (vvTopo) was produced and purified by 
bacteriophage λ methods adapted from Shuman et al. (1988) and Sambrook et al. (1989). 
BL21 was used because it is a strain of E. coli that is deficient in proteases and thus may 
yield a sufficient amount of product. The E. coli suppressor strain LE392 was the host 
bacteriophage λ strain and pet3C was the vector used, containing a pet backbone 
expression vector and vaccinia topoisomerase I insert. pet3C DNA mini preparation was 
completed via the products and handbook instructions of the Qiagen® Mini Prep Kit. 
Corey Smith fractionated the expressed vvTopo over a Heparin column (Poros) using the 
AKTA purification system and ran the two makor peaks on an 15% SDS-polyacrylamide 
gel to estimate purity and concentration. Supercoiling assays were conducted to 
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determine the adequate amount of vvTopo needed for complete relaxation of DNA for 
use in future assays.  
pBSKS+ dsDNA 
 Plasmid pBSKS+ was streaked on an LG + amp plate, incubated overnight, and a 
single colony was grown up overnight in LB broth. Qiagen® Plasmid Purification kit was 
used for the ultrapurification of the plasmid pBSKS+ dsDNA. The purified DNA was run 
on a 1% agarose minigel containing ethidium bromide (0.5mg/mL) and compared to Hi-
Lo™ DNA marker to determine the purity of the DNA. The majority of the DNA was in 
supercoiled form. This DNA was used in the supercoiling assays in both the experimental 
samples and as a comparison marker.  
Yeast whole cell extract 
  A student in the Kaufman Lab had previously grown a large stock of yeast cells 
to late log phase (O.D.600 ~ 1.0). Cells were harvested via centrifugation and frozen drop-
wise in liquid nitrogen (LN2). Cells were ground in LN2 for 30 minutes with a mortar and 
pestle, collected, and resuspended in equal volume 2X A Buffer2 containing 100mM 
NaCl (final). Clarification was performed via ultra-centrifugation with a Beckman Ti45 
rotor for 1 hour at 100,000 x g. Protein concentration was confirmed by Bradford assay. 
Supernatent was used for fractionation via chromatography.  
Fractionation of yeast extract 
AKTA Ion Exchange Chromatography system was used to fractionate yeast 
whole cell extract (WCE). The yeast WCE was fractionated over a column of Q-
                                                 
2 A Buffer is composed of 25mM Tris-HCl pH 7.5, 1mM EDTA, 10% glycerol, 0.01% NP40.  
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sepharose Fast Flow resin, obtained from GE Health Care. Q sepharose is an anion 
exchanger resin. The flow through was collected, as well as fractions eluted by A Buffer 
at various salt concentrations (0.2, 0.4, and 1.0M NaCl)3.  
The second fractionation of the yeast WCE involved the fractionation of 64mg of 
YQ0.4 over a column of SP-sepharose resin. A Buffer was prepared at various salt 
concentrations (100mM, 200mM, 400mM and 1.0M NaCl) with protease inhibitors (1.0 
μg/mL aprotin, 0.5 μg/mL leupeptin, 0.7 μg/mL pepstatin, 1.0 μg/mL E64, 1mM 
benzamidine, and 1.1 μg/mL phosphoramidon), 1mM dithiothreitol (DTT), and 0.1mM 
phenylmethyl sulfonyl fluoride (PMSF).  Resin was equilibrated in completed A Buffer 
(100mM NaCl). Resin and YQ0.4 (20mg YQ0.4 per 1mL resin) were incubated while 
mixing at 4ºC for one hour. Mixture was centrifuged for 3 minutes at 2500 rpm. 
Supernatant was removed and kept as flow through (FT). Completed A Buffer (100mM 
NaCl) was added to the resin/YQ0.4 mixture, loaded into the column and washed with 
3X the column volume. Fractions were collected and protein was determined by addition 
of Bradford reagent. Samples were collected from the flow through and at 0.2M, 0.4M, 
and 1,0M NaCl4. For each of the three salt concentrations, the samples which appeared 
the most concentrated (via color change of Bradford reagent) were pooled. These three 
fractions were dialyzed overnight and conductivity was assessed with a conductivity 
meter. Bradford Assay was conducted to determine protein concentration in each of the 
three samples. 
                                                 
3 NOTE: The fractions of yeast WCE which were collected from the Q sepharose column at 
various salt concentrations are denoted as YQFT, YQ0.2, YQ0.4, and YQ1.0.  
 
4 NOTE: The fractions of YQ0.4 which were collected from the SP sepharose column at various salt 
concentrations are denoted as YQ0.4SPFT, YQ0.4SP0.2, YQ0.4SP0.4, and YQ0.4SP1.0. 
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Immunoblot 
 Samples to be examined for the presence of H3 by immunoblotting were run on a 
17% SDS-PAGE gel. All YQ and YQ0.4SP fractions were tested, along with yeast WCE. 
The histone H3 levels of the yeast extracts were compared to varying amounts of H3 (0.2, 
0.4, 0.8, and 1.6pmol) on the gels. Immunoblotting was performed according to the 
protocol for Immunoblotting with ECL Detection (Appendix B) in order to determine the 
presence of histone H3 in the yeast extracts. The primary antibody, αH3 (1:3000) was 
derived from rabbit (Abcam). Secondary antibody αRabbit (1:5000) was horseradish 
peroxidase linked and derived from donkey (GE Health Care). The blot was incubated 
with ECL and visualized on film.  
Supercoiling Assays 
Biochemical assays were modified from conditions described in Green et al. 
(2005). These assays involved replication-independent chromatin assembly of yeast 
extracts and were utilized to demonstrate CAF-1-mediated (and later Asf1-mediated) 
histone deposition in vitro. Upon addition of pre-bound CAF-1-H3/H4 to the yeast 
extracts and DNA plasmid, the desired result is greater supercoiling of the DNA with 
increasing amounts of pre-bound CAF-1-H3/H4. Topoisomerase was used to relax the 
DNA. Beginning with this relaxed form, the addition of histone chaperones and histones 
should allow nucleosome formation on the plasmid DNA which triggers supercoiling. 
Chromatin formation was monitored by the extent of supercoiling of plasmid DNA 
molecules upon agarose gel electrophoresis. Supercoiled DNA is compacted and runs 
farther through the gel matrix. Relaxed DNA occupies a larger volume and is retarded to 
a greater extent in the gel matrix, relative to compacted supercoiled DNA. Nicked DNA 
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cannot supercoil and occupies a greater volume than both relaxed and supercoiled DNA, 
resulting in the greatest amount of retardation.   
The general protocol of the supercoiling assays included the following steps, but 
was modified as indicted during the progression of the project. A non-replication DNA 
mixture, combined on ice, was composed of 20mM Tris pH 7.8, 1mM DTT, 5mM 
EDTA, 0.1mg/mL BSA, 100mM NaCl, 100ng pBSKS+ dsDNA, and type 1 
topoisomerase b (90 ng/reaction). The order of addition is important. Type I 
topoisomerase b (hTopo and later vvTopo) was used to relax the DNA. To ensure this 
process, the mixture was incubated for 10 minutes at 30ºC and then returned to ice. 
Chromatin assembly reactions were set up with the addition of 25µL yeast fraction, 25µL 
of the mixture containing DNA, varying amounts of pre-bound CAF-1-H3H4 complex, 
and dH2O to make 36µL. CAF-1 was pre-bound to histone tetramer (H3/H4)2 for 20 min 
at 30ºC before addition to the chromatin assembly reactions. Pre-bound CAF-1-H3H4 
complex was generally added in increasing amounts from 0.0pmol up to as much as 1.8 
pmol. These reactions were incubated at 30ºC for 1 hour to assure that the tetramer was 
deposited first, as it is in vivo. 100ng H2A/H2B dimer was added to each reaction and 
incubated for an additional 30 minutes at 30ºC to allow deposition of the dimer, flanking 
the tetramer on the DNA. A stop mix containing 40mM EDTA, 0.2% SDS, 40mg/mL 
RNAase was combined at room temperature. 60µL of this stop mix was added to each 
reaction and incubated at 37ºC for 20 minutes. A mixture of pronase (1.25 mg/mL) in TE 
pH 8.0 was prepared. 80µL was added to each reaction and incubated at 37ºC for one 
hour. To each reaction, 1µg glycogen and 10% 3M sodium acetate was added. 200µL of 
49.5% phenol, 49.5% chloroform, and 1% isoamylalcohol was added to each reaction. 
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All reactions were vortexed and centrifuged for 10 minutes at 14K rpm at room 
temperature. The aqueous phase was removed and added to 560µL 100% EtOH and 
vortexed. Reactions were incubated at -20ºC for 20 minutes to overnight. Reactions were 
centrifuged at 14K rpm at 4ºC for 20 minutes. Supernatant was aspirated and discarded. 
Pellets were washed in 500µL 75% EtOH and centrifuged at 14K rpm at 4ºC for 10 
minutes. Supernatant was aspirated and discarded. Pellets were dried for 10 minutes 
under vacuum. Dried pellets were resuspended in 15µL TE Buffer and vortexed for 5 
minutes. 5µL 6X load dye was mixed to each resuspended pellet. Samples were 
compared to negative controls which did not contain any yeast extract. A pBSKS+ 
dsDNA marker was used. All samples were run on a 1% agarose gel overnight (for 
roughly 800 Volt-hours), stained with ethidium bromide and visualized under UV light 
with the CCD camera and the Lab Works software program. 
 
Figure 2. Supercoiling Assay Model.  
 17
Heat Shock 
Certain yeast extract samples were heat shocked in 100°C for 3 minutes prior to 
addition of DNA/CAF-1 to denature endogenous proteins. Thus, if a heat-sensitive 
protein was the source of activity, a lack of supercoiling activity would result from heat 
shock treatment.  
RNAaseA 
 Certain yeast extract samples were treated with RNAaseA and incubated at 30ºC 
for 15 to 20 minutes prior to their addition into the chromatin assembly reactions. RNA 
has previously been identified as a histone deposition factor (Nelson, 1981), so this 
treatment was designed to rule out the possibility that the appearance of supercoiling 
activity was due to RNA. Inhibition of histone deposition, thus inhibition of the 
appearance of supercoiling, would demonstrate that RNA was in fact the histone 
deposition factor involved.  
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Chapter 3. RESULTS 
Supercoiling Assay of YQ Fractions (Figure 3) 
Yeast WCE was fractionated over a Q-sepharose Fast Flow column and proteins were 
eluted at 0.2M, 0.4M, and 1.0M NaCl. In addition to these fractions, the flow through 
was collected. All fractions were assayed with varying amounts of CAF-1-H3H4 and 
compared against a negative control which did not contain any yeast fraction. The 
YQ0.4M fraction displays the most supercoiling activity, as there appears to be greater 
supercoiling of the DNA with increasing amounts of CAF-1-H3H4. This fraction was 
then further fractionated over an SP-sepharose Fast Flow column as an attempt to further 
isolate the component(s) responsible for the supercoiling activity.  
 
Fraction: FT           0.2M          0.4M          1.0M           No Frac Control
CAF: - +     ++    +++    - +     ++    +++   - +     ++    +++    - +     ++    +++     - +     ++    +++    ds DNA  
       
 
Figure 3. Non-Replicative Assay of YQ Fractions. All samples are from the YQ fractions. FT denotes flow 
through. 0.2M, 0.4M, and 1.0M refers to the NaCl concentration at which the fractions were eluted. Amounts of pre-
bound CAF-1-H3H4 are 0.0, 1.0, 1.5, and 2.0 ρmol and denoted by -, +, ++, +++.  All samples were compared 
against a negative control which did not contain any yeast fraction. dsDNA serves as a marker for supercoiled 
products.  
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Protein Concentration of TQ0.4SP Fractions 
The YQ0.4M fraction was further fractionated over an SP-sepharose gel filtration 
column. Proteins were eluted at 0.2M, 0.4M, and 1.0M NaCl. The flow through was also 
collected.  For each of the three salt concentrations, the fractions which appeared the 
most concentrated (via color change of Bradford reagent) were pooled. Dialyzed samples 
were tested using a Bradford Assay to determine protein concentration in each of the 
three samples. 
Table 2. YQ0.4SP Protein Concentration 
Fraction [mg/mL] 
YQ0.4SPFT 1.69 
YQ0.4SP0.2 0.37 
YQ0.4SP0.4 2.86 
YQ0.4SP1.0 0.52 
 
Supercoiling Assay of YQ0.4SP Fractions with heat shock or RNAase (Figure 4) 
The YQ0.4SP fractions were assayed with varying amounts of CAF-1-H3H4. 
Additionally, each fraction was heat shocked or treated with RNAase to help determine if 
the appearance of supercoiling activity could be attributed to protein or RNA. All 
YQ0.4SP fractions were compared against a negative control which did not contain any 
yeast fraction, and also against the YQ0.4M fraction from the previous experiment to test 
for reproducibility. Double stranded DNA was used as a marker for supercoiled products. 
Lack of decrease in activity in the heat shocked samples may mean either that the activity 
is not protein dependent, or that a very stable protein is accountable for the activity, This 
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protein would either be stable at 100°C, or able to re-nature itself and maintain activity 
after the treatment. This is a small concern, but inconclusive. Lack of decrease in activity 
of the RNAase treated samples suggests that RNA is not responsible for the supercoiling 
activity. There does not appear to be a significant amount of supercoiling in any of the 
YQ0.4SP fractions, suggesting that perhaps the components responsible for the activity 
were separated and eluted in multiple steps from the SP column. To assess this 
possibility, the YQ0.4SP fractions were combined pairwise and tested in an additional 
assay. 
 
Fraction: FT           0.2M         0.4M          1.0M            Q0.4              No Frac
CAF:         - +   ++   HS  R   - +    ++   HS  R - +   ++   HS  R    - +   ++   HS   R    - +   ++   HS  R   - +   ++   ds DNA  
               
 
Figure 4. Non-Replicative Assay of YQ0.4SP Fractions. FT denotes flow through. 0.2M, 0.4M, and 1.0M refers to 
the NaCl concentration. Increasing amounts of CAF-1-H3H4 (0.0, 0.5, and 0.75 ρmol denoted as -, +, ++) were 
tested. HS denotes heat shock treatment and R denotes treatment with RNAase. Both the HS and R samples 
contained 0.75 ρmol CAF-1-H3H4. All YQ0.4SP fractions were compared against the YQ0.4 fraction, against a 
negative control which did not contain any yeast fraction, and a dsDNA marker for supercoiled products.  
 
H3 Histone Detection in YQ and YQ0.4SP Fractions (Figure 5) 
An immunoblot of YQ and YQ0.4SP fractions was used to detect the presence of histone 
proteins in each fraction sample. The presence of histones in the yeast fractions could 
account for supercoiling activity in samples lacking the addition of CAF-1-H3H4. The 
flow through, 0.2M, 0.4M, 1.0M NaCl fractions of both the Q fractions and Q0.4SP 
fractions were compared against the yeast whole cell extract and varying amounts of 
histone H3/H4 tetramer in order to determine the presence of H3 protein in each sample. 
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When loading the samples, the yeast whole cell extract (WCE) spilled over into the 
adjacent lanes (SP1.0, T0.2, and T0.4). Histones are slightly detectable in the WCE and 
YQ0.4SP1.0M NaCl fraction, but do not seem to be present in a significant 
concentration. The appearance of histones in the YQ0.4SP1.0 fraction but not in the 
YQ0.4 sample may be accounted for by the fractionation process. Upon fractionation, it 
is possible that histones have been concentrated enough to be detected by the western 
blot. However, it is possible that there is not any detectable amount of histones in the 
YQ0.4SP1.0 fraction, due to the spill-over from the WCE lane. This would indicate that 
the only source of histones in the experiments is the known added amount, allowing 
determination of CAF-1 dependent assembly. 
                           
 
Figure 5. Western Blot of YQ and YQ0.4SP fractions for histone detection. The flow through, 
0.2M, 0.4M, 1.0M NaCl fractions of both the Q fractions and Q0.4SP fractions were compared 
against the yeast whole cell extract and a positive control of varying amounts of tetramer (0.2, 
0.4, 0.8, and 1.6 ρmol) in order to determine the presence of histone H3 protein in each sample. 
Molecular weights are measured in Daltons. MW of H3: 15D, MW H4: 11.4D 
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Supercoiling Assay of Pairwise YQ0.4SP Fractions (Figure 6) 
The YQ0.4SP fractions were combined pairwise and tested in this assay to assess the 
possibility that components responsible for the activity were separated and eluded in 
multiple steps from the SP column. The fractions that were tested contained 25mM 
EDTA. Additional EDTA concentrations (5mM and 10mM) were tested without any 
yeast fraction in order to titer the amount of EDTA necessary for topoisomerase activity 
in the experiment. It appeared that 5mM EDTA would be sufficient because there is very 
little detectable supercoiling with 5mM EDTA, and no detectable activity with 10mM 
EDTA. Of the unpaired samples, the YQ0.4SP0.4 fraction shows greater supercoiling 
activity with increasing amounts of CAF-1-H3H4. Thus, the supercoiling activity in the 
pairwise YQ0.4SPFT/ YQ0.4SP0.4 and YQ0.4SP0.2/YQ0.4SP0.4 samples does not 
appear significant, since it is most likely due to the YQ0.4SP0.4 fraction alone. However, 
the YQ0.4SPFT/YQ0.4SP1.0 samples display a significant amount of supercoiling with 
increasing amounts of CAF-1-H3H4 because neither fraction displayed supercoiling 
activity alone. This suggests there may be components in each fraction that are required 
together in order for supercoiling to occur.  
Figure 6. Non-Replicative Assay of Pairwise YQ0.4SP Fractions. FT denotes flow through. 0.2M, 0.4M, and 
1.0M refers to the NaCl concentration. All possible combinations of the YQ0.4SP fractions were tested. Each 
sample was tested with varying amounts of CAF-1-H3H4 (0.0, 0.5, and 0.8 pmol). “5” and “10” denote samples 
with 5mM and 10mM EDTA respectively, and contain only DNA (no fraction, CAF-1-H3H4, or histone dimer) 
which were tested in order to titer the amount of EDTA required for the assay. All YQ0.4SP samples were compared 
against the YQ0.4 fraction, against a negative control which did not contain yeast fraction, and a dsDNA marker. 
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Supercoiling Assay of YQ0.4SP Fractions + HS, RNAase, and titering (Figure 7) 
The seemingly promising fractions were assayed again with additional tests. To help 
determine if the supercoiling activity was due to protein or RNA, the YQ0.4SPFT, 
YQ0.4SP1.0 and YQ0.4SP4.0 were heat shocked or treated with RNAase. There does not 
appear to be any significant decrease in activity, demonstrating that RNA is not 
accountable for supercoiling. The heat shock treatment is once again inconclusive, as 
discussed in the results of the “Supercoiling Assay of YQ0.4SP Fractions with heat shock 
or RNAase” experiment. However, there did not appear to be any significant amount of 
supercoiling in the samples without the treatments either. Additionally in the assay, the 
amount of YQ0.4SP4.0 fraction was titered in order to determine how much was needed 
to yield detectable amounts of supercoiling. The normal amount of YQ0.4SP0.4 fraction 
(25μL) did not yield supercoiling activity. Therefore, the fact that the lower amounts 
yielded slightly less activity was an insignificant result. Here, the combination 
YQ0.4SPFT/YQ0.4SP1.0 samples did not yield same results as the previous experiment. 
There was no detectable supercoiling, as the previous experiment displayed. All 
conditions were the same, except the EDTA concentration (5mM here vs. 25mM in the 
previous experiment). The lower concentration was used because the previous 
experiment yielded results suggesting that 5mM EDTA was sufficient. The lack of 
reproducibility is a problem. An additional negative result of this assay is the presence of 
supercoiling in the “no fraction” control where there is no CAF-1-H3H4 or yeast fraction 
present. The results of this assay were inconclusive. An assay was then conducted to re-
examine the supercoiling activity of the combined YQ0.4SPFT/YQ0.4SP1.0 fractions 
and the YQ0.4SP4.0 at 5mM verses 25mM EDTA (results not shown). No supercoiling 
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was detected in any of the samples. To avoid any variability caused by the EDTA 
concentration, a non-replicative assay was conducted using ATP in place of EDTA. 
 
Frac: FT/1.0                           0.4                                12μL       8μL       4μL       1μL      No Frac
______________________________   _______________________________  ______  ______  ______   _____  _________
H    H   H      R    R   R                       H    H   H      R    R   R 
CAF: - +    ++      - +      ++      - +      ++       - +      ++    - +      ++     - +     ++      - +      - +      - +      - +      - +      ++    ds  
                
 
Figure 7. Non-Replicative Assay of YQ0.4SP Fractions, with heat shock, RNAase, and tittering. The combined 
YQ0.4SPFT/YQ0.4SP1.0 fractions and the YQ0.4SP4.0 fraction were tested. Each sample was tested with varying 
amounts of CAF-1-H3H4 (0.0, 0.5, and 0.8pmol). Varying amounts of YQ0.4SP4.0 were tested (25, 12, 8, 4, and 1 
μL) in order to titer the amount required for supercoiling activity. All samples were compared against a negative 
control which did not contain any yeast fraction, and a dsDNA marker. 
 
 
Supercoiling Assay of YQ Fractions with ATP in place of EDTA (Figure 8) 
To avoid any variability caused by the EDTA concentration via topoisomerase activity or 
ATP-dependent activity, a non-replicative assay was conducted using Mg2+ (8mM) and 
ATP (1mM) in place of EDTA. The YQ fractions and the combined 
YQ0.4SPFT/YQ0.4SP0.2 fractions were tested with varying amounts of CAF-1-H3H4. 
The YQ0.2 fraction yielded supercoiling with 1.2pmol CAF-1-H3H4. This appears to be 
specific CAF-1-H3H4 activity, although it is unclear why there was not detectable 
supercoiling with 1.5pmol CAF-1-H3H4. The YQ1.0 fraction displayed supercoiling in 
each sample, including the sample that did not contain any CAF-1-H3H4, suggesting that 
there may be either ATP-dependent or CAF-1-independent factors in that fraction. The 
negative and positive controls appear to be working, suggesting that the other results of 
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the assay are reliable. The YQ0.2 fraction was then fractionated over an SP column for 
further experimentation. 
 
 
Frac:         FT        0.2            0.4        1.0             SP FT/0.2     No Frac
CAF:         - +    ++   +++  - +    ++   +++   - +   ++  +++  - +   ++  +++   - +    ++  +++   - +    ++         ds marker  
                   
 
Figure 8. Non-Replicative Assay of YQ fractions (FT, 0.2, 0.4, and 1.0M NaCl) and the combined 
YQ0.4SPFT/YQ0.4SP0.2 fractions with Mg2+ (8mM) and ATP (1mM) in place of EDTA. The fractions were tested 
with varying amounts of CAF-1-H3H4 (0.0, 0.8, 1.2, and 1.5pmol) and compared against the negative control 
(contined no yeast fraction) and the dsDNA marker.  
 
 
Supercoiling Assay of YQ0.2SP fractions + ATP; CAF-1 vs. Asf1 (Figure 9) 
The YQ0.2 fraction was further fractionated over an SP-sepharose column and eluted at 
0.2M, 0.4M, and 1.0M NaCl. The flow through was also collected. The YQ0.2SPFT, 
YQ0.2SP 0.2, YQ0.2SP0.4, and YQ0.2 fractions were assayed using ATP and Mg2+. The 
samples were tested with CAF-1-H3H4 versus Asf1-H3H4. There does not appear to be 
any specific CAF-1 or Asf1 activity. None of the fractions display greater supercoiling 
activity with increasing amounts of neither CAF-1 nor Asf1. There is little detectable 
supercoiling activity present at all.  
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Frac:         FT           0.2            0.4              Q0.2          No Frac .     
CAF:     - + ++ +++ - - - - + ++ +++ - - - - + ++ +++ - - - + ++ +++  - - - ds - + ++ +++ - - -
ASF:     - - - - +  ++ +++ - - - - + ++ +++ - - - - +  ++ +++ - - - - +  ++ +++ ds - - - - +   ++ +++  
               
 
Figure 9. Non-Replicative Assay of YQ0.2SP fractions with ATP (1mM), Mg2+ (8mM), and CAF-1-H3H4 vs. Asf1. 
The YQ0.2SPFT, YQ0.2SP 0.2, YQ0.2SP0.4, and YQ0.2 fractions were assayed using ATP. Samples were tested 
with CAF-1-H3H4 (0.0, 0.8, 1.2, 1.5pmol) versus Asf1-H3H4 (0.0, 0.8, 1.2, 1.5pmol) and compared against a 
negative control (not containing any yeast fraction) and a dsDNA marker. 
 
 
Further Experiments were Inconclusive (results not shown) 
All additional attempts to isolate components necessary for supercoiling activity were 
unsuccessful. YQ fractions were combined pairwise and assayed, but there was 
significant supercoiling in samples that did not contain CAF-1-H3H4. To determine if the 
stock of topoisomerase 1 was not working effectively, a new dilution of the 
topoisomerase was prepared. The experiment was repeated, but did not yield any 
supercoiling activity in any of the samples. Undialyzed fractions of the YQ0.2M NaCl 
fractions were tested with CAF-1-H3H4 versus Asf1 with ATP, but the results did not 
display any specific activity from the histone chaperones. Finally, human fractions from 
an S column were combined pairwise with YQ0.2 fractions and assayed with ATP and 
CAF-1-H3H4 (0.0 and 1.2pmol). No specific activity was detected. The results of this 
study remain inconclusive. 
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Chapter 4. DISCUSSION 
 
Outcome of Project Objectives 
The project objective was to isolate stimulatory factors which are necessary and sufficient 
for histone deposition by CAF-1 and/or Asf1 in the yeast Saccharomyces cerevisiae 
extracts. Assay components including histones, Asf1, CAF-1, topoisomerase, and dsDNA 
were successfully purified. Yeast extracts were successfully fractionated over a Q-
Sepharose anion exchange column and a SP-Sepharose cation exchange column. 
Fractions were collected at flow through, 200mM, 400mM, and 1M NaCl. 
Immunoblotting was used in order to detect the presence of histone H3 in the fractionated 
yeast samples. There did not appear to be a significant amount of histone H3 in any of the 
fractionated samples. Supercoiling assays were utilized to demonstrate CAF-1-mediated 
(and later Asf1-mediated) histone deposition in vitro. However, the biochemical 
supercoiling assay conditions proved problematic. Heat shock and RNAase experiments 
were conducted within the supercoiling assays to determine if proteins or RNA were 
responsible for the supercoiling activity. The involvement of RNA was ruled out by the 
RNAase treatment; the heat shock treatment experiments are inconclusive (Figure 4, 
Figure 7). Intermediate cofactors involved in histone deposition were not identified.  
Inconclusive Results 
Through the progression of this study, the supercoiling assays did not yield reproducible 
results. Promising data was not able to be duplicated. Multiple freezing and thawing of 
the assay components is a possible explanation for this. Initial activity was lost after 
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repeating the experiment under the same conditions (repeated experiment results not 
shown). Possible instability of proteins could make it difficult to work around. Fractions 
also seemed to be unstable at low concentrations. The YQ0.4 fraction was initially 
pursued due to its apparent activity, (Figures 3, 4, 6) but after repeated experimentation, 
there seemed to be little activity (Figure 7). The results from pairwise addition of 
YQ0.4SPFT/YQ0.4SP1.0 samples (Figure 6) display a significant amount of supercoiling 
with increasing amounts of CAF-1-H3H4 because neither fraction displayed supercoiling 
activity alone, suggesting there may be components in each fraction that are required 
together in order for supercoiling to occur. When the experiment was repeated with 
additional tests for the involvement of protein and RNA in the supercoiling activity 
(Figure 7), the results proved not to be reproducible, as no supercoiling was achieved in 
the repeated experiment. Additionally, it is possible that optimal conditions for the assay 
were not met. For example, the use of ATP and Magnesium in place of EDTA seemed to 
work more effectively, but still did not yield desired and reproducible results. It is 
possible that the best concentration combinations were not used or that other conditions 
in the assay were not optimal. The results of this study were limited by the efficiency of 
assay conditions. It would be beneficial to experiment with these assay conditions in the 
future in order to improve the supercoiling assay.  
Heat Shock and RNAase Experiments 
Heat shock experiments were designed to demonstrate if proteins were responsible for the 
supercoiling activity. Certain yeast extract samples were heat shocked as an attempt to 
denature endogenous proteins in the extract. Thus, if a heat-sensitive protein was the 
source of activity, a lack of supercoiling activity would result from heat shock treatment. 
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However, some proteins can re-nature, and some are not susceptible to denaturement at 
100°C. Considering the stability of histone chaperones, it is very possible that the 
cofactor proteins being sought in this study are stable enough to maintain activity after 
this heat shock treatment. In such a case, there would be no resulting change in the 
appearance of supercoiling activity with and without heat shock treatment, which is what 
the results depict (Figure 4, Figure 7). Therefore, it is not of immense concern that there 
was virtually no change in supercoiling activity in heat shocked samples. However, if 
activity was not protein related, this could also explain the heat shock results. Other 
factors such as RNA and polyglutamine have the ability to charge-sheild histones, 
allowing their transfer on to the DNA (von Holt, 1989). The involvement of RNA was 
ruled out by the RNAase treatment (Figure 4, Figure 7). The heat shock treatment 
experiments are inconclusive.  
 
Future of this Study 
Although isolation of intermediates involved in stimulating nucleosome assembly was 
not achieved, it remains a possibility. Given more time, the use of ATP and Magnesium 
in place of EDTA seems promising. Similarly, a parallel study in the Kaufman Lab using 
human cell extracts in place of yeast cell extracts has demonstrated the advantage of ATP 
and Magnesium over EDTA. Corey Smith is currently working on this study and has 
recently improved the replicative supercoiling assay for use with human cell extracts. The 
goal of his study is the same as this study, but utilizes a different source of proteins. The 
improved assay involves a better “bait,” PCNA, as CAF-1 binds to PCNA in vivo. PCNA 
is a processivity clamp which increases the efficiency of DNA polymerase. The assay 
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involves using a nicked DNA template loading PCNA via RFC. Results currently seem 
promising. The same assay could be used for yeast extracts.  
Merits  
Although the desired results of this study were not achieved, many tangible products 
were purified for the Kaufman lab. Assay components including CAF-1, Asf1, hTopo, 
vvTopo, pBSKS+ dsDNA, and yeast Saccharomyces cerevisiae extracts were purified and 
will be useful for future experiments. Furthermore, I gained much experience in areas of 
biochemical research techniques and practices such as protein purification, cloning, SDS-
PAGE, agarose gel electrophoresis, chromatography, immunoblotting, and staining.  
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APPENDIX A.  Asf1 Purification via AKTA 
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APPENDIX B. Immunoblotting Protocol 
Immunoblotting (western blots) with ECL detection  Paul Kaufman 6/95 
 
1.  Wear gloves whenever handling nitrocellulose.  Cut a  9.5 x 10.5 cm piece for each minigel.   
 Prewet nitrocellulose paper in water: lay down onto water surface evenly, holding edges to ensure 
even wetting.  Let sit on water surface several minutes, submerge, and then equilibrate in transfer buffer. 
 
2.  Just before electrophoresis is completed, mark appropriate gel lanes by loading methylene blue.  
(Dissolve a "pinch" of this dye in running buffer + ficoll or glycerol so it sinks.)  Turn gel back on, and run 
until methylene blue reaches top of separating gel.  This dye will transfer permanently to filter, marking 
lane position. 
 
3.  Set up transfer:  Cut five  9.5 x10.5 cm Whatman 3mm sheets for each minigel. Wet transfer cassette 
sponges and 4 of the Whatman sheets (2/ side) in transfer buffer.  Pick up gel with 1 dry Whatman sheet, 
place on one side of sandwich.  Overlay pre-equilibrated nitrocellulose sheet onto gel in one smooth motion 
while holding edges.  Don't move filter once layed down!  Close cassette and insert into Hoefer tank 
containing transfer buffer. 
 
4.  Transfer for 1 hour at 0.5 A constant current using high amperage power supply.  Remove sandwich 
from tank, stain filter with Ponceau S for total protein (2 min), score marker bands with a pencil.  Wash off 
stain by rocking in PBS + 0.1 % Tween 20 several minutes. 
 
5.  Block filter:  Make fresh 5% Carnation nonfat dry milk in PBS + 0.1 % Tween 20 by mixing on a stir 
plate several minutes.  Add to blot; incubate 1 hour at room temp., or overnight at 4oC. 
 
6.  Primary antibody:  Diluted in  PBS + 0.1 % Tween 20 + 3%BSA.  Ascites diluted 1:1000 can be reused 
several times.  Affinity purified rabbit polyclonal anti-p48 diluted 1:1000 can only be used once, however. 
 Incubate 1 hour at room temp., or overnight at 4oC. 
 
7.  Wash 5x with PBS + 0.1 % Tween 20, ~ 5 minutes per wash. 
 
8.  Secondary antibody:  Horseradish peroxidase (HRP)-coupled antibody from Amersham.  Dilute 1: 
20,000 in PBS + 0.1 % Tween 20, 10 ml per blot.  (1:10,000 may give better signal).  Incubate 20 minutes- 
1 hour at room temp. 
 
9.  Wash 5x with PBS + 0.1 % Tween 20, ~ 5 minutes per wash. 
 
10.  Develop:  Remove wash solution.  Add freshly mixed developer solution, rock for 1 minute.  Remove 
filter from liquid, drain off excess, and wrap filter in Saran.  Mark with fluorescent dots.  Expose to film.  
(Mulitple exposures per piece of film are a good idea; for strong signals, a 15 second exposure can be more 
than adequate!  Weak signals will require up to an hour.) 
 
11.  Developer: Amersham ECL solutions #1 and 2. 
 Mix 0.75 ml of each per blot being developed, then add water to a final volume of 10 ml per blot.  
Use immediately. 
 
12.  Stripping and reprobing.  Remove antibodies in 62.5 mM Tris-Cl, pH6.8, 2% SDS.  Add fresh 0.1 M 
β-mercaptoethanol (1/140 dilution of pure liquid stock).  Incubate at 50oC for 30 minutes.  Rinse well with 
water (until stench goes away!) and then with PBS + 0.1% Tween 20 twice.  Reblock and reprobe with a 
new primary antibody as above. 
 
Solutions 
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 10X Ponceau S: 2 % solution, in 30% TCA, 30% sulfosalicylic acid. 
1X diluted working stock can be reused many times. 
 
 Transfer buffer: 1 X Na Carbonate buffer + 20% MeOH.  Can reuse 5 times; keep in closed 
bottle to prevent alcohol evaporation. 
 
 40X Na Carbonate Buffer: 42.19 g NaHCO3 (84 g/mol) 
     36.7   g Na2CO3  (106 g/mol) 
 Dissolve in 1500 ml water.  pH to 9.5 with HCl.  Bring up to 1800 ml. 
 Place in 2 1 L bottles.  Autoclave. 
 
 10X PBS: For 1 liter:  80 g NaCl 
      2.0 g KCl 
      9.2 g anhydrous Na2HPO4 (Dibasic) 
      2.0 g KH2PO4 (Monobasic) 
 
 10 X SDS Gel Running Buffer:  For 8 liters:  
      242.4 g Tris base 
      1154 g glycine 
      80 g SDS 
 Add solids to carboy 2/3 filled with stirring water-let stir for a long time to dissolve. DO NOT 
AUTOCLAVE solutions that contain SDS. 
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